Riverside, CT, United States of America

Harold D Doshan

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Harold D. Doshan: Innovator in Pharmaceutical Chemistry

Introduction

Harold D. Doshan is a notable inventor based in Riverside, Connecticut, recognized for his contributions to pharmaceutical chemistry. With a total of five patents to his name, he has made significant advancements in the field of opioid receptor antagonists and their applications.

Latest Patents

Among his latest patents is the invention titled "Synthesis of (R)-N-methylnaltrexone." This invention focuses on the stereoselective synthesis of R-MNTX and its intermediates, along with pharmaceutical preparations that include R-MNTX or its intermediates, and methods for their use. Another significant patent is "Peripheral opioid receptor antagonists and uses thereof," which provides a compound formula and methods of manufacture that are useful as peripheral mu opioid receptor antagonists in treating the side effects of opioid administration.

Career Highlights

Throughout his career, Harold has worked with prominent companies in the pharmaceutical industry, including Progenics Pharmaceuticals, Inc. and Wyeth. His work has contributed to the development of innovative solutions in pain management and opioid-related therapies.

Collaborations

Harold has collaborated with notable professionals in his field, including Julio Perez and Alfred A. Avey. These collaborations have further enhanced his research and development efforts.

Conclusion

Harold D. Doshan's innovative work in pharmaceutical chemistry, particularly in the area of opioid receptor antagonists, has made a lasting impact on the industry. His patents and collaborations reflect his commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…